The role of the VEGF family in coronary heart disease

Y Zhou, X Zhu, H Cui, J Shi, G Yuan, S Shi… - Frontiers in …, 2021 - frontiersin.org
The vascular endothelial growth factor (VEGF) family, the regulator of blood and lymphatic
vessels, is mostly investigated in the tumor and ophthalmic field. However, the functions it …

Effects of aging on angiogenesis

J Lähteenvuo, A Rosenzweig - Circulation research, 2012 - Am Heart Assoc
Aging is a dominant risk factor for most forms of cardiovascular disease. Impaired
angiogenesis and endothelial dysfunction likely contribute to the increased prevalence of …

Gene therapeutic strategies for peripheral artery disease and new opportunities provided by adeno-associated virus vectors

LM Khachigian, RL Varcoe, T Suoranta… - … and Vascular Biology, 2023 - Am Heart Assoc
Peripheral artery disease (PAD) is a vascular disorder caused by occlusive atherosclerosis,
which commonly impairs blood flow to the lower extremities. The prevalence of PAD is …

Structural determinants of vascular endothelial growth factor-D receptor binding and specificity

VM Leppänen, M Jeltsch, A Anisimov… - Blood, The Journal …, 2011 - ashpublications.org
Vascular endothelial growth factors (VEGFs) and their tyrosine kinase receptors (VEGFR-1-
3) are central mediators of angiogenesis and lymphangiogenesis. VEGFR-3 ligands VEGF …

AdVEGF-B186 and AdVEGF-DΔNΔC induce angiogenesis and increase perfusion in porcine myocardium

J Nurro, PJ Halonen, A Kuivanen, M Tarkia, A Saraste… - Heart, 2016 - heart.bmj.com
Objective Coronary heart disease remains a significant clinical problem, and new therapies
are needed especially for patients with refractory angina for whom the current therapies do …

Vascular endothelial growth factor (VEGF)-D stimulates VEGF-A, stanniocalcin-1, and neuropilin-2 and has potent angiogenic effects

S Jauhiainen, SK Häkkinen, PI Toivanen… - … , and vascular biology, 2011 - Am Heart Assoc
Objective—The mature form of human vascular endothelial growth factor-D (hVEGF-
DΔNΔC) is an efficient angiogenic factor, but its full mechanism of action has remained …

Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance

MG Achen, SA Stacker - Growth Factors, 2012 - Taylor & Francis
Vascular endothelial growth factor-D (VEGF-D) is a secreted glycoprotein that promotes
growth of blood vessels (angiogenesis) and lymphatic vessels (lymphangiogenesis), and …

Comparison of efficiency and function of vascular endothelial growth factor adenovirus vectors in endothelial cells for gene therapy of placental insufficiency

C Rossi, M Lees, V Mehta, T Heikura, J Martin… - Human Gene …, 2020 - liebertpub.com
Severe fetal growth restriction (FGR) affects 1: 500 pregnancies, is untreatable and causes
serious neonatal morbidity and death. Reduced uterine blood flow (UBF) and lack of …

The history of the WHHL rabbit, an animal model of familial hypercholesterolemia (II)-contribution to the development and validation of the therapeutics for …

M Shiomi - Journal of Atherosclerosis and Thrombosis, 2020 - jstage.jst.go.jp
A number of effective drugs have been developed through animal experiments, contributing
to the health of many patients. In particular, the WHHL rabbit family (WHHL rabbits and its …

Pro-angiogenic efficacy of transplanting endothelial progenitor cells for treating hindlimb ischemia in hyperglycemic rabbits

P Yu, Q Li, Y Liu, J Zhang, K Seldeen… - Journal of Diabetes and its …, 2015 - Elsevier
Aims To evaluate the effectiveness of endothelial progenitor cells (EPCs) therapy in
ischemia with or without hyperglycemia. Methods Japanese White Rabbits were randomly …